Title of article :
The Effect of Ventricular Assist Devices on Post-Transplant Mortality: An Analysis of the United Network for Organ Sharing Thoracic Registry
Author/Authors :
Patlolla، نويسنده , , Vishnu and Patten، نويسنده , , Richard D. and DeNofrio، نويسنده , , David and Konstam، نويسنده , , Marvin A. and Krishnamani، نويسنده , , Rajan، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2009
Pages :
8
From page :
264
To page :
271
Abstract :
Objectives tudy sought to determine the relationship between pre-transplant ventricular assist device (VAD) support and mortality after heart transplantation. ound singly, VADs are being used to bridge patients to heart transplantation. The effect of these devices on post-transplant mortality is unclear. s ts 18 years or older who underwent first-time, single-organ heart transplantation in the U.S. between 1995 and 2004 were included in the analyses. This study compared 1,433 patients bridged with intracorporeal and 448 patients bridged with extracorporeal VADs with 9,455 United Network for Organ Sharing status 1 patients not bridged with a VAD with respect to post-transplant mortality. Because the proportional hazards assumption was not met, hazard ratios (HRs) for different time periods were estimated. s orporeal VADs were associated with an HR of 1.20 (95% confidence interval [CI]: 1.02 to 1.43; p = 0.03) for mortality in the first 6 months after transplant and an HR of 1.99 (95% CI: 1.44 to 2.75; p < 0.0001) beyond 5 years. Between 6 months and 5 years, the HRs were not significantly different from 1. Extracorporeal VADs were associated with an HR of 1.91 (95% CI: 1.53 to 2.37; p < 0.0001) for mortality in the first 6 months and an HR of 2.93 (95% CI: 1.19 to 7.25; p = 0.02) beyond 5 years. The HRs were not significantly different from 1 between 6 months and 5 years, except for an HR of 0.23 (95% CI: 0.06 to 0.91; p = 0.04) between 24 and 36 months. sions orporeal VADs are associated with higher mortality within 6 months and again beyond 5 years after transplantation. Intracorporeal VADs are associated with a small increase in mortality in the first 6 months and a clinically significant increase in mortality beyond 5 years. These data do not provide evidence supporting VAD implantation in stable United Network for Organ Sharing status I patients awaiting heart transplantation.
Keywords :
mortality , Outcome , ventricular assist device , heart-assist devices , Heart transplantation
Journal title :
JACC (Journal of the American College of Cardiology)
Serial Year :
2009
Journal title :
JACC (Journal of the American College of Cardiology)
Record number :
1743853
Link To Document :
بازگشت